Papillary Thyroid Microcarcinomas: a 25 Years Retrospective, Institutional Study of 255 Cases

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press. 2004;p.54-5.Search in Google Scholar

2. YE. Nikiforov, Paul W. Biddinger, Lester D.R. Thompson. Diagnostic Pathology and Molecular Genetics of the Thyroid Second Edition- Chapter 7 - Thyroid Tumors: Classification, Staging and General Considerations, Chapter 11- Papillary Carcinoma, Lippincott Williams & Wilkins. 2012;108-118,183-243.Search in Google Scholar

3. Kahn C, Simonella L, Sywak M, et al. Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroi. 2012;(22):604-10.10.1089/thy.2011.050122524497Search in Google Scholar

4. Davies L, Welch HG. Current Thyroid Cancer Trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317-322.10.1001/jamaoto.2014.124557566Search in Google Scholar

5. Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; (177):1357-61.10.1503/cmaj.061730207298618025426Search in Google Scholar

6. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;(144):980-8.10.1016/j.surg.2008.08.03519041007Search in Google Scholar

7. Hughes DT, Haymart MR, Miller BS, et al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 2011;(21):231-236.10.1089/thy.2010.013721268762Search in Google Scholar

8. Furio Pacini. Thyroid microcarcinoma. Best Practice & Research Clinical Endocrinology & Metabolism. 2012;421-429.10.1016/j.beem.2012.07.00122863385Search in Google Scholar

9. Grodski S, Brown T, Sidhu S, et al. Increased incidence of thyroid cancer is due to increased pathologic detection. Surgery. 2008;(144):1038-43.10.1016/j.surg.2008.08.02319041015Search in Google Scholar

10. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds. Thyroid. 2014;24(3):472-479.10.1089/thy.2013.0257394944723937391Search in Google Scholar

11. Furio Pacini . Management of Papillary Thyroid Microcarcinoma: Primum Non Nocere! J Clin Endocrinol Metab. 2013;98(4):1391-1393.Search in Google Scholar

12. Kitahara CM, Platz EA, Beane Freeman LE, et al. Physical activity, diabetes, and thyroid cancer risk: A pooled analysis of five prospective studies. Cancer Causes & Control. 2012;23(3):463-71.10.1007/s10552-012-9896-y358637822294499Search in Google Scholar

13. Howlander N, Noone AM, Krapcho M, et al. J. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.Search in Google Scholar

14. Leenhardt L, Grosclaude P, Cherie-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid. 2004;(14):1056-1060.10.1089/thy.2004.14.105615650358Search in Google Scholar

15. Roti E, degli Uberti EC, Bondanelli M, et al. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;(159):659-673.10.1530/EJE-07-0896Search in Google Scholar

16. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;(71):4022-4029.10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-OSearch in Google Scholar

17. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 1985;(56):531-538.10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3Search in Google Scholar

18. Kovacs GL, Gonda G, Vadasz G, et al. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid. 2005;(15):152-7.10.1089/thy.2005.15.152Search in Google Scholar

19. Sakorafas GH, Stafyla V, Kolettis T, et al. Microscopic papillary thyroid cancer as an incidental finding in patient treated surgically for presumably benign thyroid disease. Journal of Postgraduate Medicine. 2007;(53):23-26.10.4103/0022-3859.30323Search in Google Scholar

20. De Matos PS, Ferreira AP, Ward LS. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocrine Pathology. 2006;(17):165-173.10.1385/EP:17:2:165Search in Google Scholar

21. Neuhold N, Schultheis A, Hermann M. Incidental papillary microcarcinoma of the thyroid-further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol. 2011;(18):3430.10.1245/s10434-011-1663-xSearch in Google Scholar

22. Piana S, Ragazzi M, Tallini G, et al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol. 2013;44(4):556-565.10.1016/j.humpath.2012.06.019Search in Google Scholar

23. Malandrino P, Pellegriti G, Attard M, et al. Papillary thyroid microcarcinomas:a comparative study of the characteristics and risk factors at presentation in two cancer registries. JClin Endocrinol Metab. 2013;(98):1427-1434.10.1210/jc.2012-3728Search in Google Scholar

24. Besic N, Pilko G, Petric R, et al. Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol. 2008;(97):221-5.10.1002/jso.20935Search in Google Scholar

25. Yu XM, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;(254):653-660.10.1097/SLA.0b013e318230036d21876434Search in Google Scholar

26. Robenshtok E, Grewal RK, Fish S, et al. A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients. Thyroid. 2013;23(4):436-442.10.1089/thy.2012.035223067402Search in Google Scholar

27. Moon HJ, Kim EK, Chung WY. Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol. 2011;(18):1916-23.10.1245/s10434-011-1556-z21267788Search in Google Scholar

28. Zhang L, Wei WJ, Ji QH, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab. 2012;(97):1250-1257.10.1210/jc.2011-154622319042Search in Google Scholar

29. Kim BY, Jung CH, Kim JW, et al. Impact of clinicopathologic factors on subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Yonsei Med J. 2012;(53):924-930.10.3349/ymj.2012.53.5.924342384922869474Search in Google Scholar

30. Zhao Q, Ming J, Liu C, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013;(20):746-52.10.1245/s10434-012-2654-222972508Search in Google Scholar

31. Elisei R, Viola D, Torregrossa L,et al. The BRAF (V600E) mutation is an independent, poor prognostic factor for the outcome of patients with lowrisk intrathyroid papillary thyroid carcinoma: single institution results from a large cohort study. J Clin Endocrinol Metab. 2012;(97):4390-4398.10.1210/jc.2012-177523066120Search in Google Scholar

32. Virk RK, Van Dyke AL, Finkelstein A, et al. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol. 2013;26(1):62-70.10.1038/modpathol.2012.15222918165Search in Google Scholar

33. Berger N, Borda A. Pathologie thyroidienne, parathyroidienne et surrenalienne- Techniques d`etude des lesions thyroidienne. Editura Sauramps Medical Montpellier. 2010;(366):29-33.Search in Google Scholar

34. Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic Pathology and Molecular Genetics of the Thyroid Second Edition - Chapter 19 - Gross Examination, Lippincott Williams & Wilkins. 2012;403-409.Search in Google Scholar

35. Sobin LH, Gospodarowicz MK, Wittekind C. UICC TNM Classification of Malignant Tumours. 7th ed. Wiley-Liss; New York NY: 2009.10.1002/9780471420194.tnmc26.pub2Search in Google Scholar

36. Friguglietti CU, Dutenhefner SE, Brandao LG, et al. Classification of papillar thyroid microcarcinoma according to the size and fine-needle aspiration cytology: behavior and therapeutic implications. Head Neck. 2011;(33):696-701.10.1002/hed.2151720737499Search in Google Scholar

37. Buffet C, Golmard JL, Hoang C, et al. Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma. Eur J Endocrinol. 2012;(167):267-275.10.1530/EJE-12-010522648965Search in Google Scholar

38. Ross DS, Litofsky D, Ain KB, et al. Recurrence after treatment of micropapillary thyroid cancer. Thyroid. 2009;(19):1043-8.10.1089/thy.2008.040719772419Search in Google Scholar

39. Kim K, Kim S, Lee YS, et al. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: A retrospective study of 2,309 consecutive patients. Annals of Surgical Oncology. 2015;22(1):125-31.10.1245/s10434-014-3899-825092159Search in Google Scholar

40. Ortiz Sebastian S, Rodriguez Gonazles JM, Parilla Paricio P, et al. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg. 2000;(135):272-27710.1001/archsurg.135.3.27210722027Search in Google Scholar